Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27620890 | 1.00 | MEN1 (0.55) | MEN1KMT2AUSP2TSHRMAPK1 | |
| SCHEMBL12050435 | 1.00 | MEN1 (0.55) | MEN1KMT2AUSP2TSHRMAPK1 | |
| SCHEMBL541678 | 1.00 | MEN1 (0.55) | MEN1KMT2AUSP2TSHRMAPK1 | |
| SCHEMBL11352485 | 1.00 | MEN1 (0.55) | MEN1KMT2AUSP2TSHRMAPK1 | |
| SCHEMBL867745 | 1.00 | MEN1 (0.55) | MEN1KMT2AUSP2TSHRMAPK1 | |
| SCHEMBL7697770 | 0.95 | — | — | |
| SCHEMBL269833 | 0.95 | — | — | |
| Ethylene Glycol SCHEMBL27538538 | 0.92 | USP2 (0.54) | MEN1KMT2AUSP2TSHRMAPK1 | |
| SCHEMBL28011925 | 0.92 | USP2 (0.54) | MEN1KMT2AUSP2TSHRMAPK1 | |
| Hydrochloric Acid SCHEMBL28194872 | 0.92 | USP2 (0.54) | MEN1KMT2AUSP2TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115715934-A | Ethylene-chlorotrifluoroethylene copolymer hollow fiber membrane and membrane casting solution thereof | 阿克菲姆膜材(嘉兴)有限公司 | 2023-02-28 | — | — | CN | claimed |
| US-20170267717-A1 | Novel method for the production of 18F-labeled active esters and their application exemplified by the preparation of a PSMA-specific PET-tracer | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2017-09-21 | — | — | US | claimed |
| EP-3183236-A1 | METHOD FOR THE PRODUCTION OF 18F-LABELED ACTIVE ESTERS AND THEIR APPLICATION EXEMPLIFIED BY THE PREPARATION OF A PSMA-SPECIFIC PET-TRACER | Max-Planck-Gesellschaft zur Förderung der Wissenschaften (DE) | 2017-06-28 | — | — | EP | claimed |
| WO-2016030329-A1 | METHOD FOR THE PRODUCTION OF 18F-LABELED ACTIVE ESTERS AND THEIR APPLICATION EXEMPLIFIED BY THE PREPARATION OF A PSMA-SPECIFIC PET-TRACER | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-03-03 | — | — | WO | claimed |
| EP-0595500-B1 | Non-swelling polyurethane, softenable by contact with a liquid | BECTON DICKINSON CO (US) | 1999-08-18 | — | — | EP | claimed |
| EP-0595500-A2 | Non-swelling polyurethane, softenable by contact with a liquid | Becton, Dickinson and Company (US) | 1994-05-04 | — | — | EP | claimed |
| US-5266669-A | Medical devices | BECTON, DICKINSON AND COMPANY (US) | 1993-11-30 | — | — | US | claimed |
| CN-115715934-B | Ethylene-chlorotrifluoroethylene copolymer hollow fiber membrane and casting solution thereof | 阿克菲姆膜材(嘉兴)有限公司 | 2023-07-04 | — | — | CN | disclosed |
| US-11660844-B2 | Composite polymer films | DUPONT TEIJIN FILMS U.S. LIMITED PARTNERSHIP (US) | 2023-05-30 | — | — | US | disclosed |
| US-11628652-B2 | — | — | 2023-04-18 | — | — | US | disclosed |
| CN-115715934-A | Ethylene-chlorotrifluoroethylene copolymer hollow fiber membrane and membrane casting solution thereof | 阿克菲姆膜材(嘉兴)有限公司 | 2023-02-28 | — | — | CN | disclosed |
| US-20200269552-A1 | COMPOSITE POLYMER FILMS | DUPONT TEIJIN FILMS U.S. LIMITED PARTNERSHIP (US) | 2020-08-27 | — | — | US | disclosed |
| US-9853228-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2017-12-26 | — | — | US | disclosed |
| US-5008004-A | Aromatics extraction process having improved water stripper | UOP (US) | 1991-04-16 | — | — | US | disclosed |
| US-4886726-A | UNIFORM, HIGH QUALITY COPY IMAGES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-12-12 | — | — | US | disclosed |
| US-4680336-A | SOFT CONTACT LENSES, DILUENTS | VISTAKON, INC. (US) | 1987-07-14 | — | — | US | disclosed |
| EP-0193327-A1 | Low viscosity gas dehydrating agents and gas sweetening agents | THE DOW CHEMICAL COMPANY (US) | 1986-09-03 | — | — | EP | disclosed |
| EP-0182659-A2 | Shaped hydrogel articles | JOHNSON & JOHNSON VISION PRODUCTS, INC. (US) | 1986-05-28 | — | — | EP | disclosed |
| EP-0042622-A1 | Spiro[2,2,6,6-tetramethyl-piperidine-4,2'-(1',3'-dioxo(ol)an]-derivatives and stabilizers for synthetic polymers | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1981-12-30 | — | — | EP | disclosed |
| US-4119681-A | UNSATURATED POLYESTERS, URETHANE PREPOLYMER | VESELOVSKY ROMAN ALEXANDROVICH | 1978-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170267717-A1 | Novel method for the production of 18F-labeled active esters and their application exemplified by the preparation of a PSMA-specific PET-tracer | FGB, F13B, FAP | MEN1 288/4885KMT2A 2206/4885USP2 4322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.